Prinzmetal angina is a form of chest pain caused by a sudden, temporary spasm of a coronary artery rather than by a permanent blockage from plaque buildup. Unlike the more common type of angina that strikes during physical exertion, Prinzmetal angina tends to hit at rest, often between midnight and early morning, and it can affect people whose arteries look perfectly clean on imaging. The condition was first described in 1959 by cardiologist Myron Prinzmetal, roughly two centuries after William Heberden published the original clinical description of typical angina.1The Journal of Emergency Medicine. William Heberden and Myron Prinzmetal: Angina pectoris Although treatable and carrying a generally favorable long-term outlook, the condition is easily missed or mistaken for a heart attack, and understanding what drives it matters for getting the right care.
How It Differs From Typical Angina
Most angina results from stable atherosclerotic plaque that narrows a coronary artery. During exercise or stress, the heart demands more oxygen, and the narrowed artery cannot deliver enough blood. The pain is predictable: it shows up with exertion and eases with rest. Prinzmetal angina works differently. The artery itself clamps down in a spasm that can temporarily choke off blood flow just as effectively as a fixed blockage. Because the spasm is transient, it can happen in arteries that have no significant plaque at all, though some patients do have underlying atherosclerosis as well.
The timing is the most distinctive clue. Episodes cluster in the early morning hours, typically between midnight and 8 a.m. One study demonstrated this dramatically: when patients with Prinzmetal angina performed treadmill tests in the early morning and again in the afternoon, spasm-related ECG changes appeared in all 13 patients during the morning session but in only 2 of 13 during the afternoon.2PubMed. Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: role of exercise-induced coronary arterial spasm That kind of time-dependent vulnerability does not occur with fixed blockages.
What Causes the Spasm
Two intertwined problems drive the coronary spasm: the smooth muscle in the artery wall contracts too forcefully, and the inner lining of the artery fails to counterbalance that contraction. In a healthy artery, endothelial cells produce nitric oxide, a molecule that relaxes smooth muscle and keeps the vessel open. In patients with Prinzmetal angina, nitric oxide production is reduced or its effects are blunted, leaving the artery prone to constriction.3PubMed. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina That deficiency also explains a clinical quirk: the affected arteries tend to be hypersensitive to nitroglycerin, which works by donating nitric oxide directly, because they are so starved of the molecule to begin with.
On the smooth-muscle side, a signaling enzyme called Rho-kinase plays a central role. Rho-kinase acts like a molecular switch that sustains muscle contraction beyond what normal signals would produce. Inflammatory molecules in the artery wall can ramp up Rho-kinase activity, making the smooth muscle hyperreactive.4PubMed. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells Research has identified inflammation in the adventitia, the outermost layer of the artery wall, as a key driver of this Rho-kinase upregulation.5PubMed Central. Mechanisms of Coronary Artery Spasm The combination of too little relaxation signal from the endothelium and too much contraction signal from Rho-kinase creates a vessel primed to clamp shut at relatively minor provocations.
There is also a genetic angle. A specific variation in the gene that produces the enzyme responsible for making nitric oxide in blood vessels has been linked to Prinzmetal angina. In a study of patients carrying this variation, supplementation with L-arginine, a building block the body uses to produce nitric oxide, significantly improved symptom satisfaction and reduced angina frequency when added on top of standard medications.6PubMed. The endothelial nitric oxide synthase T-786c mutation, a treatable etiology of Prinzmetal’s angina This finding is still considered preliminary, but it underscores how individual biology shapes who develops the condition and how severe it becomes.
The Role of the Autonomic Nervous System
The body’s autonomic nervous system, the network that controls heart rate, blood pressure, and vessel tone without conscious thought, appears to play a significant role in triggering spasm episodes. Research monitoring patients during spontaneous spasm attacks found that a withdrawal of vagal (parasympathetic) tone often preceded the spasm, rather than a surge in adrenaline-driven sympathetic activity as you might expect.7Journal of the American College of Cardiology. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina In practical terms, that means the autonomic fluctuations that occur naturally during sleep cycles, particularly during the transition from deeper to lighter sleep stages in the early morning, likely contribute to the characteristic nocturnal timing of attacks.
Triggers and Risk Factors
Cigarette smoking stands out as the single most important modifiable risk factor. Unlike classic coronary artery disease, where smoking is one item on a long list of contributors, smoking in Prinzmetal angina is both a chronic risk factor and a direct trigger for individual attacks.8PubMed Central. The Smoking Paradox: A Twist in the Tale of Vasospastic Angina Nicotine promotes endothelial dysfunction, increases Rho-kinase activity, and shifts autonomic balance in exactly the directions that encourage spasm. Many patients experience a marked reduction in attack frequency simply by quitting.
Cocaine is another well-documented trigger. It narrows coronary arteries, suppresses heart muscle contractility, and raises both heart rate and blood pressure simultaneously, creating a perfect storm for ischemia in a spasm-prone artery.9PubMed. The effects of acute and chronic cocaine use on the heart Cocaine-related chest pain in the emergency department should always raise the possibility of coronary vasospasm, not just atherosclerotic plaque rupture. Other stimulant drugs, alcohol, and exposure to cold can also provoke episodes in susceptible people.
Magnesium deficiency is a less well-known but clinically relevant factor. A study of men with Prinzmetal angina found a strong correlation between how severely magnesium-depleted they were and how frequently they experienced attacks.10PubMed. Relation between severity of magnesium deficiency and frequency of anginal attacks in men with variant angina Magnesium acts as a natural calcium channel blocker, helping smooth muscle relax. Patients who retain more magnesium from an intravenous load, a sign of deeper deficiency, tend to have more frequent spasm episodes. This does not mean magnesium supplements are a standalone treatment, but correcting a deficiency may help reduce attack burden alongside standard therapy.
What the ECG Shows During an Attack
The electrocardiogram during a Prinzmetal spasm looks alarming, and that is part of the diagnostic challenge. In roughly half of cases involving a spasm in a major proximal coronary artery, the first change is the appearance of tall, peaked, symmetrical T waves, followed by progressive ST-segment elevation that can mimic the pattern seen in an acute heart attack.11PubMed Central. Prinzmetal angina: ECG changes and clinical considerations: a consensus paper The critical difference is that these changes resolve within minutes as the spasm relaxes, rather than persisting or evolving the way they would in a true infarction caused by a blood clot.
This transient ECG pattern means that catching the changes requires monitoring during an actual episode. If a patient walks into a clinic between attacks, the resting ECG typically looks completely normal. That gap is one reason the condition is underdiagnosed: the evidence is only visible during the few minutes when the artery is in spasm, and most episodes happen in the middle of the night when nobody is recording.
How It Is Diagnosed
Because routine testing often turns up normal results, diagnosing Prinzmetal angina sometimes requires actively provoking a spasm under controlled conditions. The gold-standard approach uses invasive coronary angiography combined with provocative drugs, typically acetylcholine or ergonovine, which are injected directly into the coronary arteries to see whether they trigger a visible spasm.12PubMed. Pharmacological coronary spasm provocative testing in clinical practice: A French Coronary Atheroma and Interventional Cardiology Group (GACI) position paper A positive result, where the artery visibly narrows and the patient’s symptoms and ECG changes are reproduced, confirms the diagnosis.
These provocation tests are not perfect. Some patients with genuine Prinzmetal angina test negative with standard doses of a single agent. Case reports have documented patients who tested negative on acetylcholine alone but positive when both acetylcholine and ergonovine were used together, suggesting that different patients may respond to different provocative stimuli.13PubMed Central. Vasospastic Angina Diagnosed by the Spasm Provocation Test with the Combined Use of the Acetylcholine and Ergonovine Provocation Tests In practice, a negative provocation test does not definitively rule out the diagnosis if the clinical picture is convincing.
Ambulatory Holter monitoring, which records the ECG continuously for 24 to 48 hours, offers a non-invasive alternative. If the recording captures an episode of ST elevation that corresponds to the patient’s symptoms and then resolves spontaneously, that can be diagnostic without requiring catheterization. The catch is that attacks need to be frequent enough to be captured during the monitoring window, which is not always the case.
Treatment
Calcium channel blockers are the cornerstone of therapy. Drugs in this class, including nifedipine, diltiazem, and verapamil, directly relax coronary smooth muscle and counteract the spasm mechanism. They are all highly effective, and at standard doses they fully prevent angina attacks in roughly 80 to 90 percent of patients.14European Cardiology Review. Management of Coronary Artery Spasm Because of this strong response rate, calcium channel blockers are considered first-line and are usually the only long-term medication needed.15PubMed. Calcium antagonists in the treatment of Prinzmetal’s angina and unstable angina pectoris
Short-acting nitroglycerin, taken under the tongue during an acute episode, relieves spasm quickly by providing the nitric oxide that the artery’s own endothelium is failing to supply. Long-acting nitrate formulations, however, are less clearly useful for ongoing prevention. Their effectiveness at preventing spasms over the long term is questionable, so they are generally reserved as add-on therapy for patients whose calcium channel blockers are not enough on their own or cannot be increased to higher doses due to side effects.
For patients who remain symptomatic despite maximum-dose calcium channel blockers and nitrates, additional options exist. Nicorandil, a potassium-channel opener with nitrate-like properties, is sometimes used. Rho-kinase inhibitors, which directly target the molecular switch driving smooth muscle hypercontraction, represent a more mechanistically targeted approach and have shown promise in refractory cases.16PubMed. Vasospastic angina: A literature review of current evidence Statin therapy and low-dose aspirin are sometimes prescribed as well, though their benefits specifically in vasospastic angina, as distinct from atherosclerotic disease, remain unclear.
Medications That Can Make It Worse
Beta-blockers, which are standard therapy for many other forms of heart disease, occupy an uncomfortable position in Prinzmetal angina. They block the receptors that, when stimulated, promote vasodilation. In a coronary artery prone to spasm, removing that dilating influence can theoretically allow unopposed vasoconstriction and worsen attacks. Despite having clear benefits in patients with blocked coronary arteries, beta-blockers have not been shown to help in vasospastic angina, and there is ongoing concern that they may be harmful.17PubMed Central. Pharmacotherapy of Vasospastic Angina This is one of the most important distinctions in managing the condition, because a patient misdiagnosed with typical angina or a heart attack could easily be prescribed a beta-blocker that makes their spasms worse.
Triptans used for migraine, certain ergot-based medications, and high-dose caffeine also have vasoconstrictive properties that could provoke spasm in susceptible individuals. Patients with a known diagnosis of Prinzmetal angina should flag this with any prescriber, including dentists and neurologists who might not think to ask about coronary artery disease.
When Spasms Turn Dangerous
Most treated Prinzmetal angina follows a benign course, but the condition is not harmless. When a spasm is severe or prolonged enough, it can produce a full heart attack by starving heart muscle of oxygen long enough to cause tissue death. It can also trigger serious heart rhythm disturbances.18Cardiovascular Research. Increased QT dispersion in patients with Prinzmetal’s variant angina and cardiac arrest
A review of 81 patients with Prinzmetal angina found that 13 experienced angina-linked cardiac arrest and 9 died suddenly. The risk of one of these catastrophic events was roughly tripled in patients who had a history of fainting during an attack or who had documented serious arrhythmias during prior episodes.19American Heart Journal. Cardiac arrest and sudden unexpected death in variant angina: Complications of coronary spasm that can occur in the absence of severe organic coronary stenosis Syncope during a spasm episode is therefore a red flag that warrants aggressive treatment and possibly an implantable defibrillator in selected patients.
Long-Term Outlook
With appropriate treatment, the prognosis for Prinzmetal angina is generally favorable. A study following 245 patients for an average of nearly seven years reported survival rates of about 97 percent at five years and 93 percent at ten years. When heart attacks were factored in, survival without infarction was 83 percent at five years and 81 percent at ten years, and the use of calcium channel blockers improved these numbers.20PubMed. Long-term prognosis for patients with variant angina and influential factors
Another long-term study of 217 patients painted a slightly more guarded picture, with five-year survival at 89 percent and five-year survival without infarction at 69 percent.21PubMed. Long-term prognosis of patients with variant angina The difference between the two studies likely reflects variation in how aggressively patients were treated and whether they had coexisting atherosclerosis. Patients with purely vasospastic disease and no underlying plaque tend to do better than those with both conditions overlapping.
Some patients experience a natural remission over time, with attacks becoming less frequent and eventually disappearing even without medication changes. Others require lifelong therapy. Smoking cessation is consistently associated with better outcomes, and the ongoing use of calcium channel blockers remains the most clearly proven intervention for keeping the condition under control.
Who Gets Prinzmetal Angina
Prinzmetal angina defies the profile of typical coronary artery disease. Patients tend to be younger and are less likely to have the classic risk factors of high cholesterol, high blood pressure, and diabetes. Smoking, however, is extremely common in this group. The condition affects both men and women, but some data suggest women may be somewhat more likely to present with vasospastic angina, particularly premenopausal women, who are relatively protected from atherosclerotic disease but not from coronary spasm.
Geographic differences in prevalence are striking. Japanese populations appear to have higher rates of vasospastic angina compared to Caucasian populations, a pattern that has been observed in multiple studies and is thought to reflect both genetic and environmental factors. Endothelial nitric oxide synthase gene variants that predispose to reduced nitric oxide production may be more common in certain East Asian populations, which could partly explain this difference.22PubMed Central. Recent insights into the mechanisms of vasospastic angina Provocation testing is also performed more routinely in Japan, which means more cases get detected there, creating some uncertainty about whether the true incidence gap is as large as the clinical numbers suggest.
Prinzmetal Angina and MINOCA
In recent years, Prinzmetal angina has gained renewed attention as one of the recognized causes of MINOCA, which stands for myocardial infarction with non-obstructive coronary arteries. MINOCA describes a situation where a patient has clear evidence of a heart attack on blood tests and ECG, but coronary angiography reveals no significant blockage. Vasospasm accounts for a meaningful share of MINOCA cases, and recognizing Prinzmetal angina as the underlying cause changes management entirely: the patient needs calcium channel blockers, not the stents or aggressive antiplatelet therapy that would be used for a blockage.
The broader awareness of MINOCA has been a net positive for patients with vasospastic angina, because it has pushed cardiologists to think beyond fixed blockages when evaluating acute chest pain. Provocation testing is now more likely to be considered in patients whose angiograms come back clean, rather than those patients simply being reassured and sent home without a clear diagnosis. For anyone who has been told they had a heart attack with “clean arteries,” vasospastic angina is one of the possibilities worth investigating specifically.